Nitazoxanide

This classification denotes an antiprotozoal agent with the molecular formula C12H9N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SOA12P041N, chemically known as salicylamide, n-(5-nitro-2-thiazolyl)-, acetate (ester) but generally known as nitazoxanide, which bears US NIH Compound Identifier 41684. European Medicines Agency schedules Nitazoxanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09311MIG. The term NITAZOXANIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules nitazoxanide in its Anatomical Therapeutic Chemical (ATC) Classification. NITAZOXANIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nitazoxanide under HS 29341000 and SITC 51579. As of Q4 2014, NITAZOXANIDE remains the US FDA Preferred Term for this commodity. Nitazoxanide bears US NLM identifiers UMLS ID C1170029 and NCI Concept Code C47637. SMILES: S1C(NC(=O)C2C(OC(=O)C)CCCC2)NCC1[N](=O)O.